Who
Evan Lockwood Rachlin
Director
Company insider
Files Form 4 as: Director, Iambic Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 0
- Bought
- $11.5M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 14 Oct 2026
- Last trade
- 16 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeutics | SEC FORM 4 Code C | —1,458,736 | filing |
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeutics | SEC FORM 4 Code C | —410,762 | filing |
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeutics | SEC FORM 4 Bought | $11.5M718,750 at $16.00 | filing |
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeutics | SEC FORM 4 Code C | —57,754 | filing |
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeuticsoption or derivative | SEC FORM 4 Code C | —1,152,025 at $0.00 | filing |
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeuticsoption or derivative | SEC FORM 4 Code C | —57,754 at $0.00 | filing |
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeuticsoption or derivative | SEC FORM 4 Code C | —306,711 at $0.00 | filing |
| 16 Oct 2026filed 19 Oct 2026 | IAM Iambic Therapeuticsoption or derivative | SEC FORM 4 Code C | —410,762 at $0.00 | filing |
| 14 Oct 2026filed 16 Oct 2026 | IAM Iambic Therapeuticsoption or derivative | SEC FORM 4 Code A | —20,300 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.